← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oncosting Llc
Baltimore, MD
$3,761,724
Total funding
3
Grants
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,505,724 · 2
NSF$256,000 · 1
By mechanism
R44$3,505,724 · 2
—$256,000 · 1
Investigators at Oncosting Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
STING agonist-expressing BCG for bladder cancer$1,092,982
R44 · FY2023 · CA
BCG overexpressing a small molecule STING agonist as a vaccine for TB$991,112
R44 · FY2025 · AI
STING agonist-expressing BCG for bladder cancer$907,018
R44 · FY2022 · CA
BCG overexpressing a small molecule STING agonist as a vaccine for TB$270,176
R44 · FY2024 · AI
STTR Phase I: Recombinant BCG as a novel immunoadjuvant for viral infections$256,000
· FY2022 · TIP
STING agonist-expressing BCG for bladder cancer$244,436
R44 · FY2021 · CA